Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours

被引:11
作者
Mills, Logan [1 ]
Drymousis, Panagiotis [2 ]
Vashist, Yogesh [3 ]
Burdelski, Christoph [3 ]
Prachalias, Andreas [4 ]
Srinivasan, Parthi [4 ]
Menon, Krishna [4 ]
Cotoi, Corina [5 ]
Khan, Saboor [6 ]
Cave, Judith [7 ]
Armstrong, Thomas [8 ]
Weickert, Martin O. [9 ]
Izbicki, Jakob [3 ]
Schrader, Joerg [10 ,11 ]
Frilling, Andreja [2 ]
Ramage, John K. [1 ]
Srirajaskanthan, Raj [1 ]
机构
[1] Kings Coll Hosp London, Inst Liver Studies, London, England
[2] Imperial Coll, Dept Surg & Canc, London, England
[3] Univ Med Ctr, Dept Gen Visceral & Thorac Surg, Hamburg, Germany
[4] Kings Coll Hosp London, Dept Surg, London, England
[5] Kings Coll Hosp London, Dept Histopathol, London, England
[6] Univ Hosp Coventry & Warwickshire, Dept Surg, Coventry, W Midlands, England
[7] Univ Hosp, Dept Oncol, Southampton, Hants, England
[8] Univ Hosp, Dept Surg, Southampton, Hants, England
[9] Univ Hosp Coventry & Warwickshire, Dept Endocrinol, Coventry, W Midlands, England
[10] Univ Med Ctr Hamburg Eppendorf, Dept Gastroenterol, Hamburg, Germany
[11] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany
关键词
neuroendocrinology; endocrine cancers; gastrointestinal tract; pancreas; surveillance; ENDOCRINE TUMORS; NONOPERATIVE MANAGEMENT; INCIDENTAL DIAGNOSIS; SIZE; RESECTION; SURVIVAL; OUTCOMES; CLASSIFICATION; PROGNOSIS; NEOPLASMS;
D O I
10.1530/EC-17-0293
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Small non-functioning pancreatic NETs (pNETs) <= 2 cm can pose a management dilemma in terms of surveillance or resection. There is evidence to suggest that a surveillance approach can be considered since there are no significant radiological changes observed in lesions during long-term follow-up. However, other studies have suggested locoregional spread can be present in <= 2 cm pNETs. The aim of this study was to characterise the prevalence of malignant features and identify any useful predictive variables in a surgically resected cohort of pNETs. 418 patients with pNETs were identified from 5 NET centres. Of these 227 were included for main analysis of tumour characteristics. Mean age of patients was 57 years, 47% were female. The median follow-up was 48.2 months. Malignant features were identified in 38% of <= 2 cm pNETs. ROC analysis showed that the current cut-off of 20 mm had a sensitivity of 84% for malignancy. The rate of malignant features is in keeping with other surgical series and challenges the belief that small pNETs have a low malignant potential. This study does not support a 20 mm size cut-off as being a solitary safe parameter to exclude malignancy in pNETs.
引用
收藏
页码:876 / 885
页数:10
相关论文
共 30 条
[1]   Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours [J].
Bettini, R. ;
Boninsegna, L. ;
Mantovani, W. ;
Capelli, P. ;
Bassi, C. ;
Pederzoli, P. ;
Delle Fave, G. F. ;
Panzuto, F. ;
Scarpa, A. ;
Falconi, M. .
ANNALS OF ONCOLOGY, 2008, 19 (05) :903-908
[2]   Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor [J].
Bettini, Rossella ;
Partelli, Stefano ;
Boninsegna, Letizia ;
Capelli, Paola ;
Crippa, Stefano ;
Pederzoli, Paolo ;
Scarpa, Aldo ;
Falconi, Massimo .
SURGERY, 2011, 150 (01) :75-82
[3]   Sporadic nonfunctioning pancreatic neuroendocrine tumors: Prognostic significance of incidental diagnosis [J].
Birnbaum, David Jeremie ;
Gaujoux, Sebastien ;
Cherif, Rim ;
Dokmak, Safi ;
Fuks, David ;
Couvelard, Anne ;
Vullierme, Marie-Pierre ;
Ronot, Maxime ;
Ruszniewski, Philippe ;
Belghiti, Jacques ;
Sauvanet, Alain .
SURGERY, 2014, 155 (01) :13-21
[4]  
Bosman FT, 2010, WHO Classification of tumors of the digestive system, V4th
[5]   Incidental Detection of Pancreatic Neuroendocrine Tumors: An Analysis of Incidence and Outcomes [J].
Cheema, Asima ;
Weber, Jill ;
Strosberg, Jonathan R. .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (09) :2932-2936
[6]   Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors [J].
Cherenfant, Jovenel ;
Stocker, Susan J. ;
Gage, Mistry K. ;
Du, Hongyan ;
Thurow, Tiffany A. ;
Odeleye, Melanie ;
Schimpke, Scott W. ;
Kaul, Karen L. ;
Hall, Curtis R. ;
Lamzabi, Ihab ;
Gattuso, Paolo ;
Winchester, David J. ;
Marsh, Robert W. ;
Roggin, Kevin K. ;
Bentrem, David J. ;
Baker, Marshall S. ;
Prinz, Richard A. ;
Talamonti, Mark S. .
SURGERY, 2013, 154 (04) :785-791
[7]   Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors [J].
Crippa, Stefano ;
Partelli, Stefano ;
Zamboni, Giuseppe ;
Scarpa, Aldo ;
Tamburrino, Domenico ;
Bassi, Claudio ;
Pederzoli, Paolo ;
Falconi, Massimo .
SURGERY, 2014, 155 (01) :145-153
[8]   Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place [J].
de Mestier, Louis ;
Gaujoux, Sebastien ;
Cros, Jerome ;
Hentic, Olivia ;
Vullierme, Marie-Pierre ;
Couvelard, Anne ;
Cadiot, Guillaume ;
Sauvanet, Alain ;
Ruszniewski, Philippe ;
Richard, Stephane ;
Hammel, Pascal .
ANNALS OF SURGERY, 2015, 262 (02) :384-388
[9]   ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors [J].
Falconi, M. ;
Eriksson, B. ;
Kaltsas, G. ;
Bartsch, D. K. ;
Capdevila, J. ;
Caplin, M. ;
Kos-Kudla, B. ;
Kwekkeboom, D. ;
Rindi, G. ;
Kloeppel, G. ;
Reed, N. ;
Kianmanesh, R. ;
Jensen, R. T. .
NEUROENDOCRINOLOGY, 2016, 103 (02) :153-171
[10]   Outcome of surgery for pancreatic neuroendocrine neoplasms [J].
Fischer, L. ;
Bergmann, F. ;
Schimmack, S. ;
Hinz, U. ;
Priess, S. ;
Mueller-Stich, B. P. ;
Werner, J. ;
Hackert, T. ;
Buechler, M. W. .
BRITISH JOURNAL OF SURGERY, 2014, 101 (11) :1405-1412